home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Malaria Parasite Takes Advantage Of Liver

 
  October, 21 2003 8:50
your information resource in human molecular genetics
 
     
The parasite that causes malaria exploits one of the body's own chemicals to cause infection, according to a report in the November issue of Nature Medicine.

Sporozoites of the parasite, Plasmodium berghei, infect a human host by traveling through the liver, wounding several liver cells along the way before settling down in one of them. Maria Mota and colleagues discovered that the wounded cells produce a protein called hepatocyte growth factor (HGF), which is normally involved in liver development and regeneration. When the secreted HGF activates receptors on a neighboring cell, it triggers a pathway that rearranges the internal skeleton of that cell and makes it more susceptible to Plasmodium infection.

Mota's findings might explain why malaria can be more severe in hepatitis B carriers, who have more HGF than normal. The researchers also found that blocking the HGF receptors prevented Plasmodium from infecting the liver. They suggest that interfering with the HGF pathway might be the key to developing new malaria treatments.

Author contact:

Maria M. Mota
Instituto Gulbenkian de Ciencia
Oeiras, Portugal
Tel: +351 21 446 4517
E-mail: mmota@igc.gulbenkian.pt

Also available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.